Intabio

Intabio: Revolutionizing Biotherapeutic Development with iCIEF-MS Technology

Intabio is a leading biotechnology company that specializes in developing innovative solutions for biotherapeutic development. The company's flagship product, the Intabio microfluidic chip-based integrated iCIEF-MS system, is a game-changer in the field of biotherapeutics.

Biotherapeutics are complex molecules that are used to treat a wide range of diseases, including cancer and autoimmune disorders. These molecules are typically large proteins that can be modified in various ways during their production process. These modifications can impact the safety and efficacy of the drug, making it essential to identify and quantify them accurately.

The traditional method for analyzing protein modifications involves separating them based on their charge using capillary isoelectric focusing (CIEF) and then detecting them using mass spectrometry (MS). However, this approach has several limitations, including low sensitivity and poor reproducibility.

Intabio's iCIEF-MS technology overcomes these limitations by directly coupling CIEF with high-resolution MS detection for intact proteins. This approach enables the identification of post-translational modifications such as glycosylation and charge variants that can impact drug safety and efficacy.

The Intabio microfluidic chip-based integrated iCIEF-MS system offers several advantages over traditional methods. Firstly, it provides higher sensitivity than conventional CIEF-MS systems due to its unique design that minimizes sample loss during separation. Secondly, it offers improved reproducibility due to its automated sample handling capabilities.

Another significant advantage of Intabio's technology is its ability to analyze intact proteins rather than just peptides or fragments. This feature allows researchers to obtain more comprehensive information about protein modifications than other methods currently available on the market.

The Intabio system has already been adopted by several leading pharmaceutical companies worldwide for use in their biotherapeutic development programs. Its ability to provide accurate information about protein modifications quickly has made it an indispensable tool for researchers working on complex biologics projects.

In addition to its flagship product, Intabio also offers a range of services related to biotherapeutic development. These include analytical method development, validation studies, and consulting services aimed at helping clients optimize their drug discovery processes.

Overall, Intabio's innovative iCIEF-MS technology represents a significant step forward in the field of biotherapeutics analysis. Its unique features offer unparalleled accuracy and speed compared with other methods currently available on the market. As such, it is poised to become an essential tool for researchers working on complex biologics projects worldwide.